What happened to the CBA (ASX:CBA) share price in November

CBA shares had a month to forget…

| More on:
Group of thoughtful business people with eyeglasses reading documents in the office.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Commonwealth Bank of Australia (ASX: CBA) share price was out of form in November.

During the month, Australia's largest bank saw its shares tumble a disappointing 11%.

This compares to a loss of 0.9% by the S&P/ASX 200 Index (ASX: XJO).

What happened to the CBA share price in November?

Investors were selling down the CBA share price last month in response to the banking giant's first quarter update.

For the three months ended 30 September, the bank reported a 3% increase in operating income over the prior corresponding period but a 1% decline over the quarterly average during the second half of FY 2021.

But the main disappointment came from its net interest margin, which was considerably lower in the quarter. Management advised that this was driven by higher liquid asset balances, home loan price competition, switching to lower margin fixed rate loans, and the continued impact of a low interest rate environment.

This sparked fears that retail-focused banks could underperform in the near term, leading to many investors jumping ship.

Is this a buying opportunity?

While the broker community is overwhelmingly bearish on the CBA share price, there is one leading broker that remains positive.

That broker is Bell Potter. In response to its update, the broker retained its buy rating but trimmed its price target to $111.00.

Based on the current CBA share price, this implies potential upside of approximately 16% for investors over the next 12 months.

In addition, Bell Potter expects the bank's shares to provide a fully franked 4.2% dividend yield in FY 2022. Combined, this brings the total potential return to ~20%.

While its analysts were disappointed with CBA's result, they still see enough value to maintain their buy rating.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »